AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33788003 — intervention group
Group type: EXPERIMENTAL
Intervention: CTCAE vs RTOG
Number of subjects: 200
Study 33788003 — intervention group
Group type: EXPERIMENTAL
Intervention: CTCAE assessments for severe OM (WHO score ≥ 3)
Number of subjects: 200
Study 33788003 — intervention group
Group type: EXPERIMENTAL
Intervention: RTOG assessments for severe OM (WHO score ≥ 3)
Number of subjects: 200
Study 33788003 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with WHO score of 4
Number of subjects: 200
Study 32029375 — intervention group
Group type: EXPERIMENTAL
Intervention: Barium sulfate shield
Number of subjects: 0
Study 32029375 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth‐antimony shield
Number of subjects: 0
Study 32029375 — intervention group
Group type: EXPERIMENTAL
Intervention: Topogram‐based tube current modulation (TCM)
Number of subjects: 0
Study 32029375 — intervention group
Group type: COMPARATOR
Intervention: Fixed tube current
Number of subjects: 0
Study 35075525 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured behavioral support program with 7-weekly sessions
Number of subjects: 128
Study 35075525 — intervention group
Group type: COMPARATOR
Intervention: Routine post-operative care (control group)
Number of subjects: 128
Study 33048877 — intervention group
Group type: COMPARATOR
Intervention: $0 financial incentive
Number of subjects: 452
Study 33048877 — intervention group
Group type: EXPERIMENTAL
Intervention: $1.25 financial incentive
Number of subjects: 452
Study 33048877 — intervention group
Group type: EXPERIMENTAL
Intervention: $2.50 financial incentive
Number of subjects: 452
Study 33048877 — intervention group
Group type: EXPERIMENTAL
Intervention: $5.00 financial incentive
Number of subjects: 452
Study 33048877 — intervention group
Group type: EXPERIMENTAL
Intervention: $10.00 financial incentive
Number of subjects: 452
Study 33177479 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with chronic rotator cuff tears (n=12)
Number of subjects: 23
Study 33177479 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls (n=11)
Number of subjects: 23
Study 32078469 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (500 mg twice a day for 3 days)
Number of subjects: 16
Study 33843798 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention with aerobic activity and inspiratory muscle training 2 weeks pre- and 4 weeks postoperatively
Number of subjects: 668
Study 33843798 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 668
Study 32193187 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab plus MTX
Number of subjects: 44
Study 32193187 — intervention group
Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 44
Study 35179037 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir arm
Number of subjects: 201
Study 35179037 — intervention group
Group type: EXPERIMENTAL
Intervention: ART initiation
Number of subjects: 201
Study 35179037 — intervention group
Group type: EXPERIMENTAL
Intervention: Grayscale ultrasound measures
Number of subjects: 201
Study 35179037 — intervention group
Group type: EXPERIMENTAL
Intervention: Grayscale median
Number of subjects: 201
Study 35179037 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray-level difference statistic-contrast
Number of subjects: 201
Study 35179037 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy
Number of subjects: 201
Study 33784522 — intervention group
Group type: EXPERIMENTAL
Intervention: Telestroke consultation with a hub vascular neurologist
Number of subjects: 257
Study 33784522 — intervention group
Group type: COMPARATOR
Intervention: Care provided by local neurologists (pre-cohort)
Number of subjects: 257
Study 35094632 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 51
Study 32829526 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity isometric handgrip exercise
Number of subjects: 8
Study 32829526 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity isometric handgrip exercise
Number of subjects: 8
Study 32829526 — intervention group
Group type: COMPARATOR
Intervention: Regular HD (Control)
Number of subjects: 8
Study 32926507 — intervention group
Group type: EXPERIMENTAL
Intervention: pembrolizumab 200 mg every 3 weeks (35 cycles)
Number of subjects: 40
Study 32926507 — intervention group
Group type: COMPARATOR
Intervention: chemotherapy (four to six cycles)
Number of subjects: 40
Study 35130196 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2%
Number of subjects: 36
Study 35130196 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.5%
Number of subjects: 36
Study 35130196 — intervention group
Group type: EXPERIMENTAL
Intervention: Single injection
Number of subjects: 36
Study 35130196 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual injection
Number of subjects: 36
Study 34533816 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT) with taping
Number of subjects: 60
Study 34533816 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified constraint‐induced movement therapy (mCIMT) alone
Number of subjects: 60
Study 34533816 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT) alone
Number of subjects: 60
Study 34098301 — intervention group
Group type: EXPERIMENTAL
Intervention: MOUD (Medication for Opioid Use Disorder)
Number of subjects: 570
Study 34098301 — intervention group
Group type: EXPERIMENTAL
Intervention: XR-NTX (Extended-Release Naltrexone)
Number of subjects: 570
Study 34098301 — intervention group
Group type: COMPARATOR
Intervention: BUP-NX (Buprenorphine-Naloxone)
Number of subjects: 570
Study 34098301 — intervention group
Group type: COMPARATOR
Intervention: Not on MOUD
Number of subjects: 570
Study 32372454 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 12637
Study 32372454 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 12637
Study 32372454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12637
Study 34344198 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed DVD
Number of subjects: 371
Study 34344198 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed DVD plus patient navigation
Number of subjects: 371
Study 34344198 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 371
Study 34268738 — intervention group
Group type: EXPERIMENTAL
Intervention: Articaine
Number of subjects: 160
Study 34268738 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 160
Study 32020631 — intervention group
Group type: EXPERIMENTAL
Intervention: Early position change 1 hour after sheath removal
Number of subjects: 120
Study 32020631 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 36416379 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprecipitate (10 units before incision)
Number of subjects: 80
Study 36416379 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline equivalent volume)
Number of subjects: 80
Study 33063203 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin group (n=650)
Number of subjects: 2536
Study 33063203 — intervention group
Group type: COMPARATOR
Intervention: No-statin group (n=1886)
Number of subjects: 2536
Study 32928177 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu‐PSMA‐I&T
Number of subjects: 58
Study 32928177 — intervention group
Group type: COMPARATOR
Intervention: Deferred ADT (standard of care)
Number of subjects: 58
Study 35425746 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience-based intervention
Number of subjects: 1120
Study 34602484 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamin therapy (daily folic acid 0.8 mg, vitamin B12 0.5 mg, vitamin B6 20 mg)
Number of subjects: 266
Study 34602484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266
Study 35352235 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal music
Number of subjects: 38
Study 35352235 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental music
Number of subjects: 38
Study 35352235 — intervention group
Group type: COMPARATOR
Intervention: Audiobooks
Number of subjects: 38
Study 33228472 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based physical-activity intervention (Active School) including two 45 min physically active lessons, five 10 min physically active breaks, and five 10 min physically active homework.
Number of subjects: 435
Study 33228472 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 435
Study 32290829 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dextrose
Number of subjects: 60
Study 32290829 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking
Number of subjects: 60
Study 32290829 — intervention group
Group type: COMPARATOR
Intervention: Routine method (no pain relief)
Number of subjects: 60
Study 36193322 — intervention group
Group type: EXPERIMENTAL
Intervention: Fu's subcutaneous needling therapy (FSN), treated once every other day for 5 consecutive treatments.
Number of subjects: 72
Study 36193322 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture, treated once a day for 10 consecutive treatments.
Number of subjects: 72
Study 36193322 — intervention group
Group type: EXPERIMENTAL
Intervention: FSN and Acupuncture (both groups).
Number of subjects: 72
Study 32469835 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified group cognitive behavioral therapy (CBT), 8 weekly sessions of 60 minutes each
Number of subjects: 82
Study 32469835 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 82
Study 34792804 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg caffeine
Number of subjects: 181
Study 34792804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 34792804 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress
Number of subjects: 181
Study 34792804 — intervention group
Group type: COMPARATOR
Intervention: No stress
Number of subjects: 181
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: Norrbotten (13.2%), Seinäjoki‐Vaasa (14.8%), Helsinki (14.4%)
Number of subjects: 34072
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: Norrbotten (13.0%)
Number of subjects: 34072
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: Finnish areas (7.7–8.2%)
Number of subjects: 34072
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.7% to 2.7%
Number of subjects: 34072
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: Norrbotten
Number of subjects: 34072
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: Västra Götaland and Seinäjoki‐Vaasa
Number of subjects: 34072
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: More women than men
Number of subjects: 34072
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: No sex differences
Number of subjects: 34072
Study 32475292 — intervention group
Group type: EXPERIMENTAL
Intervention: Opposite found in Finland
Number of subjects: 34072
Study 32367446 — intervention group
Group type: EXPERIMENTAL
Intervention: TELEM group (telementoring)
Number of subjects: 65
Study 32367446 — intervention group
Group type: COMPARATOR
Intervention: LIVE group (live proctor)
Number of subjects: 65
Study 35856326 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibratory anesthesia
Number of subjects: 180
Study 35856326 — intervention group
Group type: EXPERIMENTAL
Intervention: Vapocoolant (cold) spray
Number of subjects: 180
Study 35856326 — intervention group
Group type: COMPARATOR
Intervention: Injection without anesthesia
Number of subjects: 180
Study 34222115 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife-led psycho-education intervention (four sessions: two group sessions during pregnancy and two individual sessions after delivery)
Number of subjects: 66
Study 34222115 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 66
Study 33570228 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllanthus emblica capsule (500 mg) twice daily for 12 weeks
Number of subjects: 150
Study 33570228 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 12 weeks
Number of subjects: 150
Study 33570228 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllanthus emblica capsule (500 mg)
Number of subjects: 150
Study 33570228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 35972854 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Health Check (N = 397)
Number of subjects: 799
Study 35972854 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (N = 402)
Number of subjects: 799
Study 33962564 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-finding using MDI
Number of subjects: 500
Study 33962564 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical assessment
Number of subjects: 500
Study 32383070 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased birthweight (1 SD lower)
Number of subjects: 183433
Study 32383070 — intervention group
Group type: COMPARATOR
Intervention: Genetically instrumented birthweight (1 SD lower)
Number of subjects: 183433
Study 32383070 — intervention group
Group type: COMPARATOR
Intervention: Genetically determined low birthweight (1 SD lower)
Number of subjects: 183433
Study 33494637 — intervention group
Group type: COMPARATOR
Intervention: Intravenous thrombolysis (IVT) only
Number of subjects: 169
Study 33494637 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT) including intra-arterial thrombolysis and mechanical thrombectomy (MT; ±IVT)
Number of subjects: 169
Study 33494637 — intervention group
Group type: COMPARATOR
Intervention: Mechanical thrombectomy (MT) only
Number of subjects: 169
Study 33494637 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT) after 2015
Number of subjects: 169
Study 34411636 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 80
Study 34411636 — intervention group
Group type: COMPARATOR
Intervention: Standard multimodal analgesia
Number of subjects: 80
Study 34032043 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 ml compound betamethasone injection
Number of subjects: 116
Study 34032043 — intervention group
Group type: COMPARATOR
Intervention: 4 ml hyaluronic acid and 1 ml compound betamethasone injection
Number of subjects: 116
Study 32437187 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaningful speech
Number of subjects: 2
Study 32437187 — intervention group
Group type: COMPARATOR
Intervention: Meaningless (foreign) speech
Number of subjects: 2
Study 32437187 — intervention group
Group type: COMPARATOR
Intervention: Silence
Number of subjects: 2
Study 35256040 — intervention group
Group type: COMPARATOR
Intervention: Maternal report of stress
Number of subjects: 548
Study 35256040 — intervention group
Group type: COMPARATOR
Intervention: Maternal psychological appraisals of stress
Number of subjects: 548
Study 35256040 — intervention group
Group type: COMPARATOR
Intervention: Maternal reports of environmental stressors
Number of subjects: 548
Study 34385478 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal stimulation
Number of subjects: 3
Study 34385478 — intervention group
Group type: COMPARATOR
Intervention: Cathodal stimulation
Number of subjects: 3
Study 34385478 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 3
Study 34999335 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid, carotenoid and vitamin E supplementation (1 g fish oil, 430 mg DHA, 90 mg EPA, 22 mg carotenoids, 15 mg vitamin E)
Number of subjects: 30
Study 34999335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34999335 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid, carotenoid and vitamin E supplementation
Number of subjects: 30
Study 34687964 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum tDCS (2 mA for 20 min over DLPFC) combined with alcohol cue ICT
Number of subjects: 125
Study 34687964 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS combined with any ICT
Number of subjects: 125
Study 34687964 — intervention group
Group type: COMPARATOR
Intervention: Any tDCS (verum or sham) combined with neutral ICT
Number of subjects: 125
Study 35073975 — intervention group
Group type: EXPERIMENTAL
Intervention: FACAM intervention
Number of subjects: 320
Study 35073975 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 320
Study 33388700 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-as-usual plus aerobic walking (TAW)
Number of subjects: 67
Study 33388700 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 67
Study 35019055 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based treatment (MBT)
Number of subjects: 113
Study 35019055 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 113
Study 36141922 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized, dynamic, and stratified intervention strategy based on an app
Number of subjects: 426
Study 36141922 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving the same intervention components of the app without the dynamic, personalized, and stratified function
Number of subjects: 426
Study 32280484 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 0
Study 32280484 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 35723758 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed + treatment
Number of subjects: 144
Study 35723758 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed - treatment
Number of subjects: 144
Study 35723758 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed + treatment (among patients with at least four lines of prior treatment)
Number of subjects: 144
Study 35723758 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed - treatment (among patients with at least four lines of prior treatment)
Number of subjects: 144
Study 34601077 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HRW) 0.5 L per day (15 ppm of hydrogen)
Number of subjects: 40
Study 34601077 — intervention group
Group type: COMPARATOR
Intervention: Control water (0 ppm of hydrogen)
Number of subjects: 40
Study 32886901 — intervention group
Group type: EXPERIMENTAL
Intervention: Upfront lanreotide (120 mg)
Number of subjects: 0
Study 32886901 — intervention group
Group type: COMPARATOR
Intervention: Active surveillance followed by lanreotide after progression
Number of subjects: 0
Study 32886901 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide price reduction scenarios
Number of subjects: 0
Study 32886901 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide long-acting release (LAR)
Number of subjects: 0
Study 35430631 — intervention group
Group type: EXPERIMENTAL
Intervention: Total menthol ban
Number of subjects: 47
Study 35430631 — intervention group
Group type: COMPARATOR
Intervention: Menthol cigarette ban
Number of subjects: 47
Study 35430631 — intervention group
Group type: COMPARATOR
Intervention: Menthol ban conditions
Number of subjects: 47
Study 32947578 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Caregivers‐Healthy Children (HC2) phase 1 intervention
Number of subjects: 2049
Study 32947578 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Caregivers‐Healthy Children (HC2) phase 2 intervention
Number of subjects: 2049
Study 32947578 — intervention group
Group type: COMPARATOR
Intervention: Control group for phase 1
Number of subjects: 2049
Study 32947578 — intervention group
Group type: COMPARATOR
Intervention: Control group for phase 2
Number of subjects: 2049
Study 36224646 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-channel PCA (16 μg/kg of fentanyl, 2 mg/kg of ketorolac, 12 mg of ondansetron)
Number of subjects: 84
Study 36224646 — intervention group
Group type: COMPARATOR
Intervention: 1-channel PCA (16 μg/kg of fentanyl, normal saline in continuous channel)
Number of subjects: 84
Study 36224646 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-channel PCA
Number of subjects: 84
Study 36224646 — intervention group
Group type: COMPARATOR
Intervention: 1-channel PCA
Number of subjects: 84
Study 35285809 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth ketogenic diet app intervention
Number of subjects: 75
Study 35285809 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth app engagement
Number of subjects: 75
Study 35285809 — intervention group
Group type: EXPERIMENTAL
Intervention: breath acetone levels
Number of subjects: 75
Study 35285809 — intervention group
Group type: EXPERIMENTAL
Intervention: compliance with weight measurements and app engagement
Number of subjects: 75
Study 34590929 — intervention group
Group type: EXPERIMENTAL
Intervention: Myo 2 g twice daily
Number of subjects: 102
Study 34590929 — intervention group
Group type: COMPARATOR
Intervention: Met 850 mg twice daily
Number of subjects: 102
Study 33686715 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual self-explanations
Number of subjects: 120
Study 33686715 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyadic explanations
Number of subjects: 120
Study 33686715 — intervention group
Group type: COMPARATOR
Intervention: Control condition (listened to the lecture once)
Number of subjects: 120
Study 33686715 — intervention group
Group type: COMPARATOR
Intervention: Control condition (listened to the lecture twice)
Number of subjects: 120
Study 32732573 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 119
Study 32732573 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood
Number of subjects: 119
Study 32732573 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 119
Study 36037999 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin administration in patients with heart failure (39 patients, 10.5%)
Number of subjects: 698
Study 36037999 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin administration in patients without heart failure (11 patients, 3.5%)
Number of subjects: 698
Study 33188745 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 0
Study 33188745 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33985509 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Comprehensive Telerehabilitation (HCTR)
Number of subjects: 782
Study 33985509 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 782